$2.570
-0.059 (-2.28%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
CRVO-Prognose durch Analyse ähnlicher Charts
Alphio's CRVO stock price prediction model matches the current CervoMed Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.60 (+0.99%). The 1-week path is $2.54 (-1.04%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich CervoMed Inc-Aktien kaufen?
CervoMed Inc is not a good buy right now due to its current price of $2.60, which is significantly below the analyst price target of $7 from Roth Capital. Additionally, the stock has a low RSI of 37.007, indicating it is nearing oversold conditions, but the overall trend remains negative with a year-to-date change of -66.62%. The main risk is the company's ongoing financial losses, with a net income of -6,571,656 USD reported for Q2 2026, which raises concerns about its sustainability and ability to fund future trials.
CRVO schloss am Tuesday bei $2.57, nachdem der Kurs -2.28% fallen
CervoMed Inc (CRVO) last closed at $2.57, losing -2.28%. These facts feed the 1-day and 1-week CRVO price prediction above.
Prognose-Treiber
Die Prognose-Treiber von CervoMed Inc (CRVO) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf CRVO am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für CRVO
Historically the probability of a positive September return for CRVO is 97.62%. October offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.